1-3 of 3
Elena Favaro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Matching-Adjusted Indirect Treatment Comparison of Epcoritamab Versus Zanubrutinib Plus Obinutuzumab in Relapsed or Refractory Follicular Lymphoma

Karen Cumings, Viktor Chirikov, Zhijie Ding, Felipe Marques Goncalves, Nicole Heaps, Savreet Bains Chawla, Anthony W Wang, Mohammad Atiya, Fernando Rivas Navarro, Elena Favaro, Daniela Hoehn, Alex Mutebi
Journal: Blood
Blood (2024) 144 (Supplement 1): 7802.
https://doi.org/10.1182/blood-2024-200799
Published: 2024
Journal Articles

Exposure-Response Analyses Supporting Optimal Epcoritamab Full Dose and Dosing Schedule in Relapsed or Refractory Follicular Lymphoma

Mahipal Gurram Sinnollareddy, Leonid Gibiansky, Kinjal Sanghavi, Steven Xu, Mohamed-Eslam F Mohamed, Poliana P. Patah, Elena Favaro, Manish Gupta, Apurvasena Parikh, Tommy Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 1414.
https://doi.org/10.1182/blood-2024-197962
Published: 2024
Journal Articles

Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion Cohort

Kim Linton, Wojciech Jurczak, Pieternella Lugtenburg, Emmanuel Gyan, Anna Maria Sureda Balari, Jacob Haaber Christensen, Brian Hess, Hervé Tilly, Raul Cordoba, David Lewis, Craig Okada, Martin Hutchings, Michael Roost Clausen, Umberto Vitolo, Tara Cochrane, Sirpa Leppa, Martine E.D. Chamuleau, Rebekah Conlon, Elena Favaro, Diana Gernhardt, Isil Altintas, Yan Liu, Catherine Thieblemont
Journal: Blood
Blood (2023) 142 (Supplement 1): 1655.
https://doi.org/10.1182/blood-2023-179887
Published: 2023